This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Tamoxifen Market

Market Insights on Tamoxifen covering sales outlook, demand forecast & up-to-date key trends

Tamoxifen Market By Type (Capsule, Tablet, Oral solution, Powder, Others), Application (Breast Cancer, Ovarian Cancer, Others), Route of Administration (Oral, Others), End User (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Region - Forecast 2022 - 2032

Tamoxifen Market Overview

The tamoxifen market was worth USD 676.6 million in 2017, and is predicted to grow to USD 683.6 million by 2025, with a CAGR of 0.07%.

Attributes

Details

Tamoxifen Market (CAGR)

0.07%

Tamoxifen Market (2025)

USD 683.6 billion

Tamoxifen is a selective estrogen receptor modulator that decreases the risk of invasive breast cancer and is used to treat estrogen receptor-positive breast cancer. It is the therapy of choice for premenopausal women. Retroperitoneal fibrosis, gynecomastia, infertility, and idiopathic sclerosing mesenteritis are all treated with tamoxifen off-label.

The emergence of combination therapies and additional therapeutic indications for tamoxifen will expand the demand for tamoxifen, as will rising cancer prevalence, rising healthcare expenditure, development of treatment options, rising government funding, rising initiatives by government and private organizations to spread awareness about breast cancer, and rising initiatives by government and private organizations to spread awareness about breast cancer.

The tamoxifen market will benefit from increased research and development efforts as well as growing economies.

However, the high cost of medication and side effects associated with tamoxifen, such as menstrual changes, hot flashes, nausea, vaginal discharge, weight loss, blurred vision, new breast lump, high calcium levels in the blood, and liver problems, will inhibit tamoxifen market growth and pose a new challenge to the sales of tamoxifen during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Growth Propellers to the Tamoxifen Market Share?

The widespread demand for tamoxifen as adjuvant therapy, as well as the proven long-term efficacy of hormone therapy for management and control of breast cancer across various stages of treatment, in geriatric patients who cannot opt for surgery and late-stage and recurrent breast cancer, are the primary factors driving demand for tamoxifen and sales of tamoxifen.

The rise of tamoxifen-resistant malignancy and increased knowledge of the drug's role in causing endometrial cancer may limit the expansion of demand for tamoxifen and sales of tamoxifen.

The growing demand for tamoxifen and sales of tamoxifen in the treatment of illnesses such McCune-Albright syndrome, infertility, gynecomastia, bipolar disorder, angiogenesis, and Riedel's thyroiditis, as well as its usage in gene expression research investigations, provide potential growth opportunities for tamoxifen market share.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What is the Region-wise Outlook of Tamoxifen Market?

The tamoxifen market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). North American region is further bifurcated into countries such as U.S. and Canada. The Europe region is further categorized into the U.K., France, Germany, Italy, Spain, Russia, and the Rest of Europe.

The Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and the Rest of Asia Pacific for the tamoxifen market.

Latin America region is further segmented into Brazil, Mexico, and the Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and the Rest of MEA for the tamoxifen market share.

The sales of tamoxifen for tamoxifen medications are seen in North America.

Due to the presence of major key players in the tamoxifen market, rising breast cancer prevalence increased awareness of breast cancer screening and prevention, high healthcare spending, and a well-developed healthcare system in this area. North America dominates the demand for tamoxifen.

Due to increased research and development activities, rising healthcare expenditure, and expanding government backing, Asia-Pacific is predicted to rise over the forecast period in addition to the increased sales of tamoxifen.

The primary drivers for the demand for tamoxifen in the Rest of the World market include increasing awareness in the Middle East and Africa, a high prevalence of late-stage breast cancer in these countries, and fast expansion of healthcare infrastructure in these regions, along with high demand for tamoxifen and sales of tamoxifen.

Who are the Major Players of Tamoxifen Market?

Allergan, AstraZeneca, Mylan N.V., Teva Pharmaceutical Industries Ltd., Apotex Inc., Midatech Pharma PLC, Bayer AG, Sanofi, Cipla Inc., WOCKHARDT, Pfizer Inc., Actiza Pharmaceutical Private Limited, Fuan Pharmaceutical (Group) Co., Ltd., and YZJ Group, among other domestic and global players, are among the major players covered in the tamoxifen market report. North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America tamoxifen market share statistics are all accessible individually.

The anticipated merger of Teva with Allergan is expected to bring a shift in market competition and demand for tamoxifen.

Future Market Insights analysts are familiar with competitive advantages and give competitive analysis for each rival individually in the tamoxifen market share.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope Of Report

Report Attribute

Details

Growth rate

CAGR of 0.07% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 – 2020

Forecast period

2022 – 2032

Quantitative units

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,

Segments covered

Type, Application, Distribution Channel, Route of Administration, End User, Region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

Allergan, AstraZeneca, Mylan N.V., Teva Pharmaceutical Industries Ltd., Apotex Inc., Midatech Pharma PLC, Bayer AG, Sanofi, Cipla Inc., WOCKHARDT, Pfizer Inc., Actiza Pharmaceutical Private Limited, Fuan Pharmaceutical (Group) Co.,Ltd., and YZJ Group

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The tamoxifen market is segmented into two types--tablets and capsules.

The tamoxifen market is segmented on basis of application into Breast Cancer, Ovarian Cancer, and Other.

Based on region, the tamoxifen market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA).

The tamoxifen market is segmented on the basis of end users, into clinic, hospital and others.

The tamoxifen market is segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate